
Pure Pharm Peptides sells research chemicals intended for laboratory use only.
You must be 18 years of age or older to access this website.
By clicking "I am 18 or Older", you confirm that you meet this age requirement.
FOR RESEARCH USE ONLY
NOT FOR HUMAN CONSUMPTION
This verification will be remembered on this device.
Scientific overviews of research peptides for laboratory and educational reference. All content is intended strictly for scientific purposes and does not constitute medical advice.
Showing 44 articles
A comprehensive overview of BPC-157, a synthetic pentadecapeptide, focusing on its molecular characteristics, research findings, mechanisms of action, and potential applications in tissue repair and angiogenesis studies.
An exploration of Semaglutide, a GLP-1 receptor agonist, focusing on its molecular characteristics, mechanism of action, and diverse research applications in metabolic and obesity studies within experimental models.
AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH176-191) studied in experimental models for its role in fat metabolism and lipolysis, without the growth-promoting effects associated with full-length hGH.
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, currently under investigation in laboratory research for its potential role in growth hormone release and metabolic regulation without the side effects associated with non-selective secretagogues.
Selank is a synthetic heptapeptide analogue of tuftsin studied in experimental models for its anxiolytic and nootropic properties, with research focusing on its modulation of GABA, serotonin, and BDNF signaling pathways.
Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Preclinical and clinical research has demonstrated significant reductions in body weight and improvements in glycemic control, positioning it as a subject of intense metabolic research.
Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Early-phase clinical research has reported unprecedented weight loss magnitudes, positioning it as one of the most potent anti-obesity compounds currently under investigation.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) stabilized by the addition of a trans-3-hexenoic acid group. Research has focused on its ability to stimulate endogenous growth hormone secretion and reduce visceral adipose tissue, particularly in the context of HIV-associated lipodystrophy.
CJC-1295 is a synthetic GHRH analogue modified with a Drug Affinity Complex (DAC) that enables covalent albumin binding, dramatically extending its half-life to 6–8 days. This extended activity profile makes it a valuable tool for research into sustained growth hormone axis stimulation.
Sermorelin is a synthetic 29-amino acid peptide corresponding to the biologically active N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH). It stimulates pituitary GH secretion through the same receptor as native GHRH and has been studied extensively as a diagnostic tool and research compound for GH axis investigation.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating GH secretion through the GHS-R1a receptor. It is one of the original synthetic growth hormone secretagogues and has been widely used in research to investigate the ghrelin axis and its role in GH regulation, appetite, and metabolic function.
GHRP-2 is a synthetic hexapeptide growth hormone secretagogue that activates the GHS-R1a receptor with higher potency than GHRP-6. It produces robust, dose-dependent GH release with comparatively less appetite stimulation, making it a widely used research tool for GH axis investigation.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring human plasma tripeptide with a high affinity for copper ions. Decades of research have implicated it in wound healing, collagen synthesis, anti-inflammatory signaling, and gene expression regulation, making it one of the most studied naturally derived peptides in regenerative medicine research.
NAD+ (nicotinamide adenine dinucleotide) is a fundamental coenzyme present in all living cells, essential for energy metabolism, DNA repair, and sirtuin activation. Research has established that NAD+ levels decline with age, and restoration of NAD+ has been studied as a potential intervention in aging-related metabolic decline.
MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome, making it one of the few known mitochondrial-derived peptides (MDPs). Research has identified roles in metabolic regulation, insulin sensitivity, exercise response, and aging, positioning MOTS-c as a novel intersection between mitochondrial biology and systemic metabolic control.
The combination of CJC-1295 and ipamorelin represents a dual-pathway approach to GH axis stimulation, pairing a long-acting GHRH analogue with a selective GHRP. Research has demonstrated that this combination produces synergistic GH release substantially greater than either peptide alone, making it a widely studied protocol in growth hormone research.
TB-500 is a synthetic version of the 43-amino acid peptide Thymosin Beta-4 (Tβ4), one of the most abundant intracellular peptides in mammalian cells. Research has identified roles in actin dynamics, cell migration, wound healing, angiogenesis, and cardiac repair, making TB-500 a subject of significant interest in regenerative medicine research.
The BPC-157/TB-500 combination pairs two of the most studied regenerative peptides in preclinical research. BPC-157 targets angiogenesis and tendon-to-bone healing through growth factor upregulation, while TB-500 promotes cell migration and actin dynamics. Together, they address complementary aspects of the tissue repair cascade.
Melanotan II is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts as a potent agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R. Research has investigated its roles in skin pigmentation, sexual function, appetite regulation, and inflammation.
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, developed in Russia and studied for neuroprotective, nootropic, and anxiolytic properties. Research has demonstrated effects on BDNF expression, dopaminergic and serotonergic systems, and cognitive function in animal models and clinical studies.
Glow Blend is a research-grade multi-peptide formulation combining GHK-Cu, Epithalon, and complementary peptides studied for their roles in skin regeneration, collagen synthesis, and cellular anti-aging mechanisms. The combination targets multiple pathways in skin biology simultaneously.
A comprehensive laboratory reference covering the principles, solvents, concentration calculations, standard procedures, and stability considerations for reconstituting lyophilized research peptides. Written for qualified researchers working with peptide compounds in laboratory settings.
A comprehensive laboratory reference covering degradation pathways, lyophilized and reconstituted peptide storage conditions, freeze-thaw cycle management, peptide-specific stability profiles, and quality assessment protocols for research-grade peptide preparations.
A comprehensive guide to the analytical methods used to characterize research peptide quality, including HPLC purity analysis, mass spectrometry identity confirmation, and how to evaluate a Certificate of Analysis.
HHS Secretary RFK Jr. announced that approximately 14 of 19 previously restricted peptides could be legally compounded again by US pharmacies within weeks. Here is what this means for the research community.
A detailed review of the dosing parameters used in published BPC-157 animal studies, including effective dose ranges, administration routes, and study duration reported in peer-reviewed literature.
A review of dosing parameters, administration routes, and study designs used in published Thymosin Beta-4 (TB-500) preclinical research, drawn from peer-reviewed literature.
A practical guide to reconstituting lyophilized research peptides using bacteriostatic water, including concentration calculations, sterile technique, and storage recommendations based on established laboratory practice.
A review of the dosing parameters, administration protocols, and study designs used in published CJC-1295 and Ipamorelin preclinical and clinical research.
A side-by-side comparison of BPC-157 and TB-500 (Thymosin Beta-4 fragment) based on published preclinical research, examining their distinct mechanisms of action, tissue targets, and research applications.
A comparison of CJC-1295 and Sermorelin as growth hormone-releasing hormone analogues, examining their structural differences, pharmacokinetics, and published research applications.
A research-based comparison of Ipamorelin and GHRP-6 as growth hormone secretagogue receptor agonists, focusing on their selectivity profiles, side effect differences in animal models, and published research applications.
A comparison of AOD-9604 and Semaglutide as research tools in metabolic studies, examining their distinct mechanisms of action, published evidence, and appropriate research applications.
An introduction to synthetic research peptides — what they are, how they differ from proteins and drugs, why they are used in laboratory research, and the regulatory framework governing their use.
A practical guide to interpreting the Certificate of Analysis for research peptides, including how to evaluate HPLC purity data, mass spectrometry identity confirmation, and common red flags that indicate poor quality documentation.
A review of the peptides most extensively studied in preclinical tissue recovery and repair models, summarizing the published evidence for each compound's research applications.
An examination of the scientific rationale for combining BPC-157 and TB-500 in tissue repair research, reviewing their complementary mechanisms and the available published evidence on combined administration.
An examination of the scientific rationale for combining a GHRH analogue (CJC-1295) with a GHSR agonist (Ipamorelin) in growth hormone research, based on the known physiology of GH secretion.
A review of GHK-Cu (copper peptide) and NAD+ as research tools in cellular repair and aging models, examining their distinct mechanisms and the published evidence for each compound.
A review of Semax and Selank as synthetic neuropeptides studied in cognitive function and anxiety models, examining their mechanisms, published evidence, and research applications.
A detailed comparison of lyophilized and reconstituted peptide storage conditions, covering degradation mechanisms, temperature requirements, and practical protocols for maintaining research-grade peptide integrity.
A research-focused overview of peptides studied for metabolic effects, including mechanisms of action, published study findings, and key differences between GLP-1 receptor agonists, lipolytic fragments, and mitochondrial regulators.
A detailed research comparison of semaglutide (GLP-1 agonist) and tirzepatide (dual GIP/GLP-1 agonist), covering receptor pharmacology, clinical trial outcomes, and the mechanistic basis for their differing efficacy profiles.
An introductory overview of the growth hormone peptide axis for researchers new to the field, covering the distinction between GHRH analogues, GHRPs, and synthetic secretagogues, with key published findings for each class.